The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients
- PMID: 29948654
- DOI: 10.1007/s11011-018-0267-6
The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients
Abstract
It is well known that hyperphenylalaninemia caused by phenylketonuria (PKU) negatively influences cognitive performance. Several tests have been used to study these functions. Until now, no universal, optimal tool has been developed for detecting PKU-caused brain dysfunctions. Using computerized neuropsychological tests during daily routine would be helpful for screening subclinical brain deficits in adult PKU patients. In a monocentric, cross-sectional study, adult patients with PKU (n = 46; median age = 29.5 years; female/male ratio = 21/25) were tested with the computerized Cambridge Cognition (CANTAB) test measuring neurocognitive functions. Patients were divided into two groups: The "on diet" group included patients whose blood Phe-level was under 600 μmol/l (n = 20), and the "loose diet" group included patients whose blood Phe-level was above 600 μmol/l (n = 26) at the examination time. The results of the PKU-affected individuals were compared with a healthy control group (n = 31; median age = 25 years; female/male ratio = 11/20). Compared with the control group, PKU patients had significantly worse test results in memory, problem-solving skills, and strategy. However, there were no significant differences in response speed or initial thinking time. There was no correlation between the blood Phe-level, tyrosine (Tyr)-level or Phe/Tyr ratio and the different cognitive test results. There were no significant differences in test results between the two PKU subgroups. Several cognitive functions measured by CANTAB are negatively influenced by hyperphenylalaninemia in adult PKU patients. However, response speed and initial thinking time were not impaired as seriously as other functions. Patients with lower Phe-levels failed to achieve better test results than patients whose Phe-levels were notably elevated.
Keywords: CANTAB; Neurocognitive functions; Phenylalanine; Phenylketonuria; Protein-restricted diet.
Similar articles
-
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter study.J Neurol. 2024 Dec 12;272(1):53. doi: 10.1007/s00415-024-12840-0. J Neurol. 2024. PMID: 39666084
-
Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.Mol Genet Metab. 2013;110 Suppl:S57-61. doi: 10.1016/j.ymgme.2013.10.011. Epub 2013 Oct 22. Mol Genet Metab. 2013. PMID: 24183792
-
Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.Trials. 2020 Feb 13;21(1):178. doi: 10.1186/s13063-019-4022-z. Trials. 2020. PMID: 32054509 Free PMC article.
-
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.Orphanet J Rare Dis. 2019 Feb 15;14(1):44. doi: 10.1186/s13023-019-1011-y. Orphanet J Rare Dis. 2019. PMID: 30770754 Free PMC article. Review.
-
Non-PKU mild hyperphenylalaninemia (MHP)--the dilemma.Mol Genet Metab. 2011 Sep-Oct;104(1-2):23-6. doi: 10.1016/j.ymgme.2011.05.007. Epub 2011 May 14. Mol Genet Metab. 2011. PMID: 21632269 Review.
Cited by
-
A systematic review of cognitive functioning in early treated adults with phenylketonuria.Orphanet J Rare Dis. 2018 Aug 30;13(1):150. doi: 10.1186/s13023-018-0893-4. Orphanet J Rare Dis. 2018. PMID: 30165883 Free PMC article.
-
Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe.Orphanet J Rare Dis. 2020 Sep 25;15(1):266. doi: 10.1186/s13023-020-01541-2. Orphanet J Rare Dis. 2020. PMID: 32977849 Free PMC article. Review.
-
Neuropsychological profile of French adults with early-treated phenylketonuria: a multicenter study.J Neurol. 2024 Dec 12;272(1):53. doi: 10.1007/s00415-024-12840-0. J Neurol. 2024. PMID: 39666084
-
Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria.Nutrients. 2023 Sep 11;15(18):3940. doi: 10.3390/nu15183940. Nutrients. 2023. PMID: 37764724 Free PMC article.
-
Saccadic reaction time and ocular findings in phenylketonuria.Orphanet J Rare Dis. 2020 May 25;15(1):124. doi: 10.1186/s13023-020-01407-7. Orphanet J Rare Dis. 2020. PMID: 32450880 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical